ZYVERSA THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.66 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-05-12
- ZYVERSA THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $1.66M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month |
|---|---|---|
| 2025-03-31 | $1.66M 10-Q · filed 2025-05-12 | |
| 2021-12-31 | $746.36K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |